Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms

Carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa (CR-PA) producing metallo-β-lactamases (MBLs) cause severe nosocomial infections with no defined treatment. The combination of aztreonam (ATM) with ceftazidime-avibactam (CZA) is a potential therapeutic option, but there is no ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Ayesha, Erickson, Samuel G., Pettaway, Cedric, Arias, Cesar A., Miller, William R., Bhatti, Micah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522751/
https://www.ncbi.nlm.nih.gov/pubmed/34424044
http://dx.doi.org/10.1128/AAC.00846-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522751/
https://www.ncbi.nlm.nih.gov/pubmed/34424044
http://dx.doi.org/10.1128/AAC.00846-21

Ejemplares similares